Brief: Ocean Biomedical Announces Newly Published Findings
03/10/2023 13:50
Oct 3 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL ANNOUNCES NEWLY PUBLISHED FINDINGS
DEMONSTRATING ABILITY TO RESTORE TREATMENT SENSITIVITY TO
ASTRAZENECA’S LEADING LUNG CANCER DRUG AFTER RESISTANCE HAS
FORMED, AND ENHANCED TUMOR SUPPRESSION IN EGFR-MUTATION LUNG
CANCERS
Source text for Eikon: ID:nGNX7S7Sm0
Further company coverage: OCEA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26